Protein assay is a widely used method in life science research. It is used to determine the amount or concentration of a specific protein in a sample. It is a necessary step in protein purification, electrophoresis, cell biology, molecular biology, and other research applications. In addition, the various type of protein assay is available in the market based on methodology, specificity, sensitivity, quantity, and reproducibility.
The global protein assay market is growing at a CAGR of 10.50% during the forecast period, 2020-2027. The major factors are the growing pharmaceutical & biotech R&D expenditure and increasing proteomics research. Additionally, the increasing prevalence of cancer and increased spending on pharmaceutical and biotechnology industry development will spur the global protein assay industry in the future periods. Furthermore, the growing public-private funding for protein quantification activities and rise in analytical technology development is expected to witness remarkable growth of protein assay. The increasing clinical usage of protein assay in the pre-clinical, clinical trial and later stages of drug development is expected to propel protein assay demand over the coming years.
Moreover, the upsurge in demand for disease diagnoses such as cancer and HIV and rising investment in drug discovery and development positively impact the market for protein assay in the healthcare industry. Furthermore, the rapid expansion in customer base, rise in the extensive R&D activities at the academic and industrial level, and increasing scope of therapeutic applications are fueling the demand for the protein assay market. The growing applications of protein assay in cell biology, molecular biology, and various other research applications will bolster the global protein assay market share growth. Additionally, the growing demand for protein content determination in various applications and increasing healthcare expenditure in the developing world propelling the growth of the protein assay market across the globe.
Protein assay or protein quantification is important for studying protein in various research topics. Moreover, protein quantitation is highly adapted in various laboratories for activities ranging from protein characterization to clinical diagnostic testing and assay drugs. Due to the advantages of large market surface, low market concentration, and gradual maturity of technology applications, protein assay has attracted various enterprises to the layout. However, stringent government regulations and a lack of trained professionals are the factors restraining the growth of the protein assay market.
Based on the type, the global protein assay market is segregated into dye-binding assays, copper-ion-based assays, test strip-based assays, and other protein assays.
The dye-binding assays segment is estimated to witness the highest growth over the analysis timeframe due to the rise in the adoption of dye-binding assays in disease diagnosis and the advantage of less susceptible to chemicals compound &easy to follow.
The copper-ion-based assays will grow significantly due to the rising adoption in industrial applications.
The global protein assay market is segregated into reagents, kits, and instruments & accessories based on the product.
The reagent segment is estimated to witness the highest growth over the analysis timeframe due to rising demand for protein quantification in research & development activities and rapid expansion in the customer base.
The instruments &accessories will grow significantly due to the rising protein assay systems adoption and the rise in the utilization of protein assay technology.
Based on the technology, the global protein assay market is categorized into absorbance-based protein assays, colorimetric-based protein assays, and fluorescence-based protein assays.
The absorbance-based protein assays segment is held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to the rising benefits, including sensitivity, high accuracy, and simple performance.
The fluorescence-based protein assays segment is poised to witness significant growth over the forecast period. It requires less protein sample for quantitation and highly adopted for automated handling in high-throughput applications.
The global protein assay market is classified into drug discovery and development, disease diagnosis, and other applications based on the application.
The disease diagnosis segment is expected to be the highest revenue share for protein assay during the forecast period. The segment’s growth is primarily allocated to the wide adoption of protein assay in disease diagnoses such as cancer, immune system diseases, and kidney, liver, and bone marrow diseases.
Drug discovery and development will witness a lucrative growth rate in the estimated period due to rising demand for drug safety and efficacy.
Based on the end-user, the global protein assay market is segmented into pharmaceutical & biotechnology companies, hospitals, clinical laboratories, academic institutes, and other end users.
The pharmaceutical & biotechnology companies segment will dominate the global protein assay market by 2027. Due to the increasing use of protein assay in the clinical trial setting and early-stage drug discovery and development.
The academic institutes accounted for the largest share of the protein assay market in 2019 because of the rising research on proteomics, economic expansion, and government focus on broader healthcare policies.
The global protein assay market is distributed into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is estimated to project fair growth over 2020-2026. It is owing to advents in technology, the presence of leading industry players offering innovative products & services, and increasing healthcare expenditure.
The Asia Pacific will capture a defined share of the protein assay market by 2027. Due to the increasing adoption rates of protein assay technologies, they are continually improving healthcare infrastructure in the region and mounting health care expenditures in emerging countries such as India and China.
Companies such as GE Healthcare Life Sciences, Bio-Rad Laboratories Inc, Cell Signaling Technology Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc, Geno Technology Inc, Lonza Group AG, Merck KgaA, Novus Biologicals LLC, Promega Corporation, and Abcam PLC are the key players in the global protein assay market.